---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-034175"
form_type: "8-K"
ticker: null
cik: "0001463361"
company_name: "Unity Biotechnology, Inc."
filed_at: "2024-03-20T23:59:59+00:00"
generated_at: "2026-06-04T11:27:46.687394+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Unity Biotechnology restates financials for warrant misclassification; net loss overstated by $15.5M in 2022

## Summary
- Audit committee determined warrants issued Aug 2022 should be liabilities, not equity; all affected periods are being restated.
- Previously reported cash, equivalents and marketable securities balances unaffected; cash runway into Q3 2025 unchanged.
- Preliminary cumulative effect: understatement of other income and overstatement of net loss by $15.5M for FY2022, $2.3M for nine months ended Sep 2023.
- Company expects at least one material weakness in internal control over financial reporting; controls deemed ineffective for restated periods.
- Restated financials will be included in 2023 10-K; prior financials for non-reliance periods should no longer be relied upon.

## SEC filing metadata
- accession: 0000950170-24-034175
- form_type: 8-K
- cik: 0001463361
- company_name: Unity Biotechnology, Inc.
- filed_at: 2024-03-20T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 4.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1463361/000095017024034175/0000950170-24-034175-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1463361/000095017024034175/ubx-20240319.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-034175
- JSON: https://secwatch.observer/filing/0000950170-24-034175.json
- Plain text: https://secwatch.observer/filing/0000950170-24-034175.txt

## Key facts
- Auditor Changes
  Unity Biotechnology, Inc. reported that prior financial statements should not be relied upon.
  - Action: non reliance
  source text: As a result, the audited and unaudited financial statements for each of the Non-Reliance Periods should no longer be relied on.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1463361/000095017024034175/0000950170-24-034175-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.